LY52 is an inhibitor of matrix metalloproteinase-2. It acts by suppressing tumor invasion and metastasis. References: Zhang H, Li X, Wang X, Xu W, Zhang J. Sulfonyl phosphonic 1,4-dithia-7-azaspiro[4,4]nonane derivatives as matrix metalloproteinase inhibitors: Synthesis, a docking study, and biological evaluation. Drug Discov Ther. 2017;11(3):118-125. doi: 10.5582/ddt.2017.01016. PubMed PMID: 28757512.

纯度：≥98%

CAS：769970-91-4